Director & 10% Owner Invests $200K in CalciMedica Private Placement
CALC sits 63% above its 52-week low of $0.461 on elevated volume (2.5× avg).
Summary
A Director and 10% owner of CalciMedica invested $200,000 in the company's recent private placement, demonstrating insider confidence.
Key Events · Ownership and Investor Activity · CALC
-
Director & 10% Owner Purchase
Fred A. Middleton, a Director and 10% owner, acquired 248,972 shares for $199,999 at a price of $0.80 per share on June 25, 2026.
-
Participation in Private Placement
This purchase was part of a Securities Purchase Agreement dated June 23, 2026, indicating participation in the company's recent capital raise, which was announced on June 24, 2026.
-
Insider Confidence Signal
The investment, made at a slight premium to the current market price, suggests strong insider belief in the company's prospects following recent positive clinical trial results and a significant financing round.
Analysis · CALC · Life Sciences
Fred A. Middleton, a Director and 10% owner, purchased nearly $200,000 worth of shares at $0.80 per share as part of a recent private placement. This investment, made at a slight premium to the current market price, signals strong insider confidence following the company's recent $49 million financing and positive clinical trial results.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CALC was trading at $0.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.9M. The 52-week trading range was $0.46 to $7.20. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.